[1] Sandell LJ, Aigner T. Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis[J]. Arthritis Res, 2001, 3(2): 107–113.
[2] Otero M, Goldring MB. Cells of the synovium in rheumatoid arthritis. Chondrocytes[J]. Arthritis Res Ther, 2007, 9(5): 220.
[3] Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis[J]. Lancet, 2010, 376(9746): 1094–1108.
[4] Scott DL. Biologics-based therapy for the treatment of rheumatoid arthritis[J]. Clin Pharmacol Ther, 2012, 91(1): 30–43.
[5] Brand DD, Latham KA, Rosloniec EF. Collagen-induced arthritis[J]. Nat Protoc, 2007, 2(5): 1269–1275.
[6] Myers LK, Rosloniec EF, Cremer MA, et al. Collagen-induced arthritis, an animal model of autoimmunity[J]. Life Sci, 1997, 61(19): 1861–1878.
[7] Maruotti N, Cantatore FP, Crivellato E, et al. Macrophages in rheumatoid arthritis[J]. Histol Histopathol, 2007, 22(5): 581–586.
[8] Bevaart L, Vervoordeldonk MJ, Tak PP. Evaluation of therapeutic targets in animal models of arthritis: how does it relate to rheumatoid arthritis?[J]. Arthritis Rheum, 2010, 62(8): 2192–2205.
[9] Carvalheiro H, da Silva JA, Souto-Carneiro MM. Potential roles for CD8(+) T cells in rheumatoid arthritis[J]. Autoimmun Rev, 2013, 12(3): 401–409.
[10] Conway JR, Carragher NO, Timpson P. Developments in preclinical cancer imaging: innovating the discovery of therapeutics[J]. Nat Rev Cancer, 2014, 14(5): 314–328.
[11] de Jong M, Essers J, van Weerden WM. Imaging preclinical tumour models: improving translational power[J]. Nat Rev Cancer, 2014, 14(7): 481–493.
[12] Schambach SJ, Bag S, Schilling L, et al. Application of microCT in small animal imaging[J]. Methods, 2010, 50(1): 2–13.
[13] Koba W, Jelicks LA, Fine EJ. MicroPET/SPECT/CT imaging of small animal models of disease[J]. Am J Pathol, 2013, 182(2): 319–324.
[14] Kim YH, Kang JS. Effect of methotrexate on collagen-induced arthritis assessed by micro-computed tomography and histopathological examination in female rats[J]. Biomol Ther (Seoul), 2015, 23(2): 195–200.
[15] Knoerzer DB, Donovan MG, Schwartz BD, et al. Clinical and histological assessment of collagen-induced arthritis progression in the diabetes-resistant BB/Wor rat[J]. Toxicol Pathol, 1997, 25(1): 13–19.
[16] Gerwin N, Bendele AM, Glasson S, et al. The OARSI histopathology initiative- recommendations for histological assessments of osteoarthritis in the rat[J]. Osteoarthritis Cartilage, 2010, 18(S3): S24–34.
[17] Batiste DL, Kirkley A, Laverty S, et al. Ex vivo characterization of articular cartilage and bone lesions in a rabbit ACL transection model of osteoarthritis using MRI and micro-CT[J]. Osteoarthritis Cartilage, 2004, 12(12): 986–996.
[18] Ishikawa T, Nishigaki F, Miyata S, et al. Prevention of progressive joint destruction in collagen-induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR255031[J]. Br J Pharmacol, 2005, 144(1): 133–143.
[19] Peterson JD, Labranche TP, Vasquez KO, et al. Optical tomographic imaging discriminates between disease-modifying anti-rheumatic drug (DMARD) and non-DMARD efficacy in collagen antibody-induced arthritis[J]. Arthritis Res Ther, 2010, 12(3): R105.
[20] Ryu JH, Lee A, Chu JU, et al. Early diagnosis of arthritis in mice with collagen-induced arthritis, using a fluorogenic matrix metalloproteinase 3-specific polymeric probe[J]. Arthritis Rheum, 2011, 63(12): 3824–3832.